Trevena, Inc.

Symbol: TRVN




Market price today

  • -0.1997

    P/E Ratio

  • -0.0047

    PEG Ratio

  • 6.37M

    MRK Cap

  • 0.00%

    DIV Yield

Trevena, Inc. (TRVN) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Ms. Carrie L. Bourdow
Full-time employees:35
Address:955 Chesterbrook Boulevard

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

General Outlook

When we look at how much money they make before expenses, they keep 0.807% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -10.754%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -9.158%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.651% return, is a testament to Trevena, Inc.'s adeptness in optimizing resource deployment. Trevena, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -3.006%. Furthermore, the proficiency of Trevena, Inc. in capital utilization is underscored by a remarkable -0.885% return on capital employed.

Stock Prices

Trevena, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.4019, while its low point bottomed out at $0.3838. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Trevena, Inc.'s stock market.

Liquidity Ratios

Analyzing TRVN liquidity ratios reveals its financial health of the firm. The current ratio of 641.29% gauges short-term asset coverage for liabilities. The quick ratio (570.68%) assesses immediate liquidity, while the cash ratio (567.77%) indicates cash reserves.

Current Ratio641.29%
Quick Ratio570.68%
Cash Ratio567.77%

Profitability Ratios

TRVN profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -959.34% underscores its earnings before tax deductions. The effective tax rate stands at 2.68%, revealing its tax efficiency. The net income per EBT, 95.46%, and the EBT per EBIT, 89.21%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -1075.43%, we grasp its operational profitability.

Pretax Profit Margin-959.34%
Effective Tax Rate2.68%
Net Income per EBT95.46%
EBT per EBIT89.21%
EBIT per Revenue-1075.43%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 6.41, it details the span from stock purchase to revenue. The 6 days it takes to settle debts showcases its creditor relations. Meanwhile, a 6 cash conversion cycle and 1791.62% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding571
Days of Inventory Outstanding532
Operating Cycle551.93
Days of Payables Outstanding913
Cash Conversion Cycle-361
Receivables Turnover17.92
Payables Turnover0.40
Inventory Turnover0.69
Fixed Asset Turnover0.63
Asset Turnover0.07

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -2.70, and free cash flow per share, -2.70, depict cash generation on a per-share basis. The cash per share value, 2.50, showcases liquidity position. Lastly, the operating cash flow sales ratio, -11.76, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-2.70
Free Cash Flow per Share-2.70
Cash per Share2.50
Operating Cash Flow Sales Ratio-11.76
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-1.07
Short Term Coverage Ratio-38.41
Capital Expenditure Coverage Ratio-4730.81
Dividend Paid and Capex Coverage Ratio-838.61

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 78.24%, highlights its total liabilities relative to assets. With a debt-equity ratio of 9.95, we discern the balance between debt and equity financing. The long-term debt to capitalization, 90.63%, and total debt to capitalization, 90.87%, ratios shed light on its capital structure. An interest coverage of -14.94 indicates its ability to manage interest expenses.

Debt Ratio78.24%
Debt Equity Ratio9.95
Long Term Debt to Capitalization90.63%
Total Debt to Capitalization90.87%
Interest Coverage-14.94
Cash Flow to Debt Ratio-1.07
Company Equity Multiplier12.72

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, -0.06, provides a glimpse into top-line earnings distributed across each share. Net income per share, -7.59, reflects the portion of profit attributed to each share. The book value per share, 2.21, represents the net asset value distributed per share, while the tangible book value per share, 2.21, excludes intangible assets.

Revenue Per Share-0.06
Net Income Per Share-7.59
Book Value Per Share2.21
Tangible Book Value Per Share2.21
Shareholders Equity Per Share2.21
Interest Debt Per Share2.97

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -173.72%, indicates top-line expansion, while the gross profit growth, -787.86%, reveals profitability trends. EBIT growth, -8.57%, and operating income growth, -8.57%, offer insights into operational profitability progression. The net income growth, -4.90%, showcases bottom-line expansion, and the EPS growth, 3.19%, measures the growth in earnings per share.

Revenue Growth-173.72%
Gross Profit Growth-787.86%
EBIT Growth-8.57%
Operating Income Growth-8.57%
Net Income Growth-4.90%
EPS Growth3.19%
EPS Diluted Growth3.19%
Weighted Average Shares Growth8.32%
Weighted Average Shares Diluted Growth8.32%
Dividends per Share Growth-91.31%
Operating Cash Flow Growth-2.55%
Free Cash Flow Growth-2.57%
10-Year Revenue Growth per Share-104.03%
3-Year Revenue Growth per Share-799.16%
10-Year Operating CF Growth per Share72.94%
5-Year Operating CF Growth per Share75.71%
3-Year Operating CF Growth per Share-12.78%
10-Year Net Income Growth per Share73.29%
5-Year Net Income Growth per Share74.90%
3-Year Net Income Growth per Share0.82%
10-Year Shareholders Equity Growth per Share3198.56%
5-Year Shareholders Equity Growth per Share-84.86%
3-Year Shareholders Equity Growth per Share-73.11%
3-Year Dividend per Share Growth per Share-87.86%
Receivables Growth-100.00%
Inventory Growth-61.48%
Asset Growth-39.24%
Book Value per Share Growth-77.72%
Debt Growth178.34%
R&D Expense Growth35.64%
SGA Expenses Growth-8.88%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -8,441,522.34, captures the company's total value, considering both debt and equity. Income quality, 0.96, assesses the reliability of reported earnings.

Enterprise Value-8,441,522.34
Income Quality0.96
Research and Development to Revenue-4356.70%
Capex to Operating Cash Flow0.05%
Capex to Revenue6.70%
Capex to Depreciation-7.33%
Stock-Based Compensation to Revenue-879.43%
Graham Number19.41
Return on Tangible Assets-110.25%
Graham Net Net0.80
Working Capital32,276,000
Tangible Asset Value15,599,000
Net Current Asset Value7,927,000
Invested Capital1
Average Receivables0.5
Average Payables3,459,500
Average Inventory1,629,000
Days Payables Outstanding287
Days of Inventory On Hand110

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.65, and the price to book ratio, 1.65, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.99, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.17, and price to operating cash flows, -0.16, gauge market valuation against cash flow metrics.

Price Book Value Ratio1.65
Price to Book Ratio1.65
Price to Sales Ratio1.99
Price Cash Flow Ratio-0.16
Enterprise Value Multiple-0.18
Price Fair Value1.65
Price to Operating Cash Flow Ratio-0.16
Price to Free Cash Flows Ratio-0.17
Price to Tangible Book Ratio0.65
Enterprise Value to Sales20.20
Enterprise Value Over EBITDA0.15
EV to Operating Cash Flow0.16
Earnings Yield-530.65%
Free Cash Flow Yield-509.27%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Trevena, Inc. (TRVN) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.200 in 2024.

What is the ticker symbol of Trevena, Inc. stock?

The ticker symbol of Trevena, Inc. stock is TRVN.

What is company IPO date?

IPO date of Trevena, Inc. is 2014-01-31.

What is company current share price?

Current share price is 0.420 USD.

What is stock market cap today?

The market cap of stock today is 6372618.000.

What is PEG ratio in 2024?

The current -0.005 is -0.005 in 2024.

What is the number of employees in 2024?

In 2024 the company has 35.